195 related articles for article (PubMed ID: 10595254)
1. Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?
Stoppa-Lyonnet D; Caligo M; Eccles D; Evans DG; Haites NE; Hodgson NS; Møller P; Morrison PJ; Steel CM; Vasen HF; Chang-Claude J
Dis Markers; 1999 Oct; 15(1-3):67-8. PubMed ID: 10595254
[No Abstract] [Full Text] [Related]
2. Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer.
Chang-Claude J; Becher H; Caligo M; Eccles D; Evans G; Haites N; Hodgson S; Møller P; Weber BH; Stoppa-Lyonnet D
Dis Markers; 1999 Oct; 15(1-3):53-65. PubMed ID: 10595253
[TBL] [Abstract][Full Text] [Related]
3. Familial breast and ovarian cancer: genetic counseling and clinical management in Italy.
Pasini B; Pierotti MA
Dis Markers; 1999 Oct; 15(1-3):41-3. PubMed ID: 10595250
[No Abstract] [Full Text] [Related]
4. Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5 + 3A > G.
Claes K; Machackova E; De Vos M; Poppe B; De Paepe A; Messiaen L
Dis Markers; 1999 Oct; 15(1-3):69-73. PubMed ID: 10595255
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer.
Møller P; Evans G; Haites N; Vasen H; Reis MM; Anderson E; Apold J; Hodgson S; Eccles D; Olsson H; Stoppa-Lyonnet D; Chang-Claude J; Morrison PJ; Bevilacqua G; Heimdal K; Maehle L; Lalloo F; Gregory H; Preece P; Borg A; Nevin NC; Caligo M; Steel CM
Dis Markers; 1999 Oct; 15(1-3):207-11. PubMed ID: 10595280
[TBL] [Abstract][Full Text] [Related]
6. Molecular cancer genetics in eastern and central Europe.
Olah E
Dis Markers; 1999 Oct; 15(1-3):75-7. PubMed ID: 10595256
[No Abstract] [Full Text] [Related]
7. The future of DNA diagnostics.
Critchfield GC
Dis Markers; 1999 Oct; 15(1-3):108-11. PubMed ID: 10595261
[No Abstract] [Full Text] [Related]
8. The future of DNA diagnostics.
Skolnick MH
Dis Markers; 1999 Oct; 15(1-3):106-7. PubMed ID: 10595260
[No Abstract] [Full Text] [Related]
9. Clinical genetic services for familial breast cancer in Poland.
Gronwald J; Menkiszak J; Huzarski T; Byrski T; Jakubowska A; Zajàczek S; Toloczko A; Podolski J; Górecka B; Zdziebkowska H; Stanislawski P; Stawicka M; Lubinski J
Dis Markers; 1999 Oct; 15(1-3):46. PubMed ID: 10595252
[No Abstract] [Full Text] [Related]
10. Hereditary susceptibility to breast cancer: significance of age of onset in family history and contribution of BRCA1 and BRCA2.
Frank TS; Deffenbaugh AM; Hulick M; Gumpper K
Dis Markers; 1999 Oct; 15(1-3):89-92. PubMed ID: 10595259
[TBL] [Abstract][Full Text] [Related]
11. The pathology of hereditary breast cancer.
Lakhani SR
Dis Markers; 1999 Oct; 15(1-3):113-4. PubMed ID: 10595262
[No Abstract] [Full Text] [Related]
12. Breast cancer genetics. Implications of clinical practice.
Olufunmilayo I; Olopade MD; Fackenthal JD
Hematol Oncol Clin North Am; 2000 Jun; 14(3):705-25. PubMed ID: 11203330
[No Abstract] [Full Text] [Related]
13. Costs and benefits of diagnosing familial breast cancer.
Heimdal K; Maehle L; Møller P
Dis Markers; 1999 Oct; 15(1-3):167-73. PubMed ID: 10595273
[TBL] [Abstract][Full Text] [Related]
14. [Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes].
Narod SA; Rodríguez AA
Salud Publica Mex; 2011; 53(5):420-9. PubMed ID: 22218796
[TBL] [Abstract][Full Text] [Related]
15. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
[TBL] [Abstract][Full Text] [Related]
16. Hereditary breast cancer and genetic counseling in young women.
Brunet J
Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():7-9. PubMed ID: 20711663
[No Abstract] [Full Text] [Related]
17. Uptake of genetic testing and pre-test levels of mental distress in Norwegian families with known BRCA1 mutations.
Reichelt JG; Dahl AA; Heimdal K; Møller P
Dis Markers; 1999 Oct; 15(1-3):139-43. PubMed ID: 10595268
[TBL] [Abstract][Full Text] [Related]
18. Management of hereditary breast cancer. European Familial Breast Cancer Collaborative Group.
Eccles DM; Simmonds P; Goddard J; Coultas M; Lalloo F; Evans G; Haites N
Dis Markers; 1999 Oct; 15(1-3):187-9. PubMed ID: 10595276
[No Abstract] [Full Text] [Related]
19. BRCA1 and BRCA2 mutations in central and southern Italian patients.
Ottini L; D'Amico C; Noviello C; Lauro S; Lalle M; Fornarini G; Colantuoni OA; Pizzi C; Cortesi E; Carlini S; Guadagni F; Bianco AR; Frati L; Contegiacomo A; Mariani-Costantini R
Breast Cancer Res; 2000; 2(4):307-10. PubMed ID: 11056688
[TBL] [Abstract][Full Text] [Related]
20. A paradox: urgent BRCA genetic testing.
Mitchell G; Ardern-Jones A; Kissin Mchir M; Taylor R; Eeles RA
Fam Cancer; 2001; 1(1):25-9. PubMed ID: 14574012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
